Atlas Trials

NSCLC (Non-small Cell Lung Carcinoma)

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch NSCLC (Non-small Cell Lung Carcinoma)

RecordFirmDate
A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia (NCT05456867)AstraZeneca2022-05-31
A Study of Atezolizumab in Combination With Epacadostat in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (NCT02298153)Incyte Corporation2015-01-27
Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations (NCT02355431)Incyte Corporation2014-12-01
Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer (NCT02257619)Incyte Corporation2014-09-24
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer (NCT02119650)Incyte Corporation2014-02-11

Track NSCLC (Non-small Cell Lung Carcinoma) automatically

Every clearance here is in the API, with alerts when new ones post.